MET and neoplasm: Among the top five results from Analysis 1 on BRCA (Table 1), four are non-tumor-related pathways: “Inflammasomes,” “PD-1 signaling,” and “antigen” are related to immune cells and “Fibrin clot formation” pathways are related to blood, except the “MET activates PTK2 signaling” pathway, which is related to the cell cycle.